LI Klepierre SA

KLÉPIERRE: INFORMATION REGARDING THE TOTAL VOTING RIGHTS AND SHARES OF KLÉPIERRE SA AS OF OCTOBER 31, 2024

KLÉPIERRE: INFORMATION REGARDING THE TOTAL VOTING RIGHTS AND SHARES OF KLÉPIERRE SA AS OF OCTOBER 31, 2024

REGULATED RELEASE

INFORMATION REGARDING THE TOTAL VOTING RIGHTS AND SHARES OF KLÉPIERRE SA AS OF OCTOBER 31, 2024(1)

Paris – November 7, 2024

NUMBER OF SHARES AS OF OCTOBER 31, 2024

Date10/31/2024
Company nameKlépierre
Trading placeEuronext Paris (Compartment A)
MnemonicLI
SymbolsEPA:LI / LI:FP / LOIM.PA
ISINFR0000121964
Total number of shares286,861,172
Total number of voting rights 
Number of theoretical voting rights(2)286,861,172
Number of exercisable voting rights(3) 285,819,074



INVESTOR RELATIONS CONTACTS 
Paul Logerot, Group Head of Investor Relations and Financial Communication

+33 (0)7 50 66 05 63 —

Hugo Martins, Investor Relations Manager

+33 (0)7 72 11 63 24 —

Tanguy Phelippeau, Investor Relations Manager

+33 (0)7 72 09 29 57 —
 

ABOUT KLÉPIERRE

Klépierre is the premier shopping malls specialist with an exclusive focus on continental Europe, combining property development and asset management skills. The Company’s portfolio is valued at €19.9 billion at June 30, 2024, and comprises large shopping centers in more than 10 countries in Continental Europe which together host hundreds of millions of visitors per year. Klépierre holds a controlling stake in Steen & Strøm (56.1%), one of the leading operators of shopping centers in Scandinavia. Klépierre is a French REIT (SIIC) listed on Euronext Paris and is included in the CAC Next 20 and EPRA Euro Zone Indexes. It is also included in ethical indexes, such as Euronext CAC 40 ESG, CAC SBT 1.5, MSCI Europe ESG Leaders, FTSE4Good, Euronext Vigeo Europe 120, and features in CDP’s “A-list”. These distinctions underscore the Group’s commitment to a proactive sustainable development policy and its global leadership in the fight against climate change.

For more information, please visit the newsroom on our website:  


(1) Provided pursuant to article l. 233-8-II of the French commercial code and article 223-16 of the general regulation of the Autorité des marchés financiers.

(2) Theoretical voting rights correspond to the total number of voting rights attached to all shares, including those deprived of voting rights (article 223-11 of the General Regulations of the Autorité des marchés financiers). As of October 31, 2024, Klépierre SA owns 1,042,098 of its own shares.

(3) Exercisable voting rights correspond to the number of voting rights net of shares deprived of voting rights.

Attachment



EN
07/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Klepierre SA

 PRESS RELEASE

KLÉPIERRE: INFORMATION REGARDING THE TOTAL VOTING RIGHTS AND SHARES OF...

KLÉPIERRE: INFORMATION REGARDING THE TOTAL VOTING RIGHTS AND SHARES OF KLÉPIERRE SA AS OF OCTOBER 31, 2024 REGULATED RELEASE INFORMATION REGARDING THE TOTAL VOTING RIGHTS AND SHARES OF KLÉPIERRE SA AS OF OCTOBER 31, 2024(1) Paris – November 7, 2024 NUMBER OF SHARES AS OF OCTOBER 31, 2024 Date10/31/2024Company nameKlépierreTrading placeEuronext Paris (Compartment A)MnemonicLISymbolsEPA:LI / LI:FP / LOIM.PA ISINFR0000121964Total number of shares286,861,172Total number of voting rights Number of theoretical voting rights(2)286,861,172Number of exercisable voting rights(3) 285,819,074INVESTO...

Benoit Valleaux ... (+2)
  • Benoit Valleaux
  • Steven Gould

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 10/23/2024

Last week, we organised an Expert Access event on multiple sclerosis (MS) with the participation of Dr Géraldine Androdias, a neurologist at Lyon University Hospital. Dr Androdias presented the key points of the ECTRIMS 2024 conference, as well as new trends in treating the illness. We note an unmet need in the primary progressive and secondary progressive forms, a real interest for the BTKi class with the greater penetration of the blood-brain barrier, and expectations for the anti-C...

Benoit Valleaux ... (+2)
  • Benoit Valleaux
  • Steven Gould

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 23/10/2024

Nous avons organisé la semaine dernière un Expert Access autour de la sclérose en plaques (SEP) avec la participation du Dr Géraldine Androdias, médecin neurologue au CHU de Lyon. Le Dr Androdias a présenté les points saillants du congrès de l’ECTRIMS 2024 ainsi que les nouvelles tendances dans la prise en charge de la maladie. Nous retenons un besoin insatisfait dans les formes progressives et secondairement progressives, un vrai intérêt de la classe des BTKi avec le passage accru de...

Florent Laroche-Joubert
  • Florent Laroche-Joubert

Klépierre : Q3 performance: another fine release likely to drive an ou...

>Very positive leading indicators with further improvements in 9M 2024 - Klépierre reported a robust operating performance as we anticipated with further improvements in leading indicators after they were already very positive in H1: Retailers’ sales in 9M 2024 rose +4.0% y-o-y at constant scope vs +3.9% in H1 2024: they rose 4.0 % at constant scope in 9M 2024 with peaks of +6.2% in August and 6.1% in September. 1/ Growth was relatively uniform by geographical re...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch